Related Experiment Video
Updated: May 10, 2026
06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Update on pediatric photosensitivity disorders.
1Department of Dermatology, Johns Hopkins University, Baltimore, Maryland 21287, USA. agrossb2@jhmi.edu
Current Opinion in Pediatrics
|July 3, 2013
Summary
Pediatric photosensitivity disorders, though rare, encompass diverse causes. Diagnosis can be achieved through an algorithmic approach, guiding further management.
Area of Science:
- Pediatric Dermatology
- Photosensitivity Disorders
- Genodermatoses
Background:
- Photosensitive dermatoses can manifest in children, originating from various causes.
- These include primary immunologically mediated conditions and inherited genetic or metabolic disorders.
Purpose of the Study:
- To review key features of pediatric photosensitivity disorders.
- To familiarize pediatric practitioners with symptoms and extracutaneous findings.
Main Methods:
- Literature review of recent advances in pediatric photosensitivity.
- Focus on diagnostic approaches and management strategies.
Main Results:
- Recent significant advances in the field of pediatric photosensitivity are limited.
- Ongoing research continues to uncover genetic underpinnings and mechanisms of photosensitivity.
Conclusions:
- A broad differential diagnosis exists for pediatric photosensitivity.
- An algorithmic diagnostic approach aids in identifying specific disorders and guiding management.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...